Financial Daily from THE HINDU group of publications
Tuesday, Oct 04, 2005
Financial Daily from THE HINDU group of publications Tuesday, Oct 04, 2005 |
|
|
|
|
|
|
|
Corporate
-
Announcements Glenmark's Goa plant gets USFDA nod Our Bureau
Mumbai , Oct. 3 MUMBAI-based Glenmark Pharmaceuticals Ltd has received regulatory approvals from the US Food and Drug Administration (USFDA) for its solid-dosage plant in Goa. The Goa facility produces formulations or finished dosage forms of medicine for international regulated markets. The plant has also received regulatory approvals from two other international bodies — Canada's Therapeutics Products Directorate and South Africa's Medicine Control Council, a company note said. The Glenmark Chief Executive Office and Managing Director, Mr Glenn Saldanha, said the filing of five abbreviated new drug applications in the US from the Goa facility triggered the USFDA inspection. He hoped to receive regulatory approvals for marketing some of these products shortly. The company has filed applications for seven drugs from the Goa facility to be marketed in the US. It plans to file 13 more this financial year, the note said.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
